RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade.
Nokin MJ, Mira A, Patrucco E, Ricciuti B, Cousin S, Soubeyran I, San José S, Peirone S, Caizzi L, Vietti Michelina S, Bourdon A, Wang X, Alvarez-Villanueva D, Martínez-Iniesta M, Vidal A, Rodrigues T, García-Macías C, Awad MM, Nadal E, Villanueva A, Italiano A, Cereda M, Santamaría D, Ambrogio C.
Nokin MJ, et al. Among authors: mira a.
Nat Commun. 2024 Aug 30;15(1):7554. doi: 10.1038/s41467-024-51828-2.
Nat Commun. 2024.
PMID: 39215000
Free PMC article.